Thromboelastographic Modifications Induced by Intravenous and Subcutaneous Heparin Administration

Clara I Traverso; Joseph A. Caprini; Juan I Arcelus; Ignacio M Arcelus

doi:10.1055/s-0032-1313622

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 1995; 21(S 04): 053-058
DOI: 10.1055/s-0032-1313622

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thromboelastographic Modifications Induced by Intravenous and Subcutaneous Heparin Administration

Clara I Traverso

^aDepartment of Surgery and Related Specialties, University of Granada Hospital, Granada, Spain

,

Joseph A. Caprini

^bDepartment of Surgery, The Glenbrook Hospital and Northwestern University Medical School, Glenview, Illinois

,

Juan I Arcelus

^cDepartment of Surgery, Hospital of the Axarquía, Vélez-Málaga (Málaga), Spain

,

Ignacio M Arcelus

^aDepartment of Surgery and Related Specialties, University of Granada Hospital, Granada, Spain

› Institutsangaben

Abstract

als PDF herunterladen

PDF (1298 kb)

Referenzen

References
1 De Nicola P. Thromboelastography. Charles C Thomas; Springfield IL: 1957: 110
2 Eliot RS, von Kaulla KN, Blount G. Thromboelastographic studies with a twenty-four-hour schedule for subcutaneous heparin. Circulation 24: 1206-1214 1961;
3 Audier M, Serradimigni A. Savoir interpreter un thrombo-elastogramme au l’exploration precise de la coagulation sanguine. Maloine; Paris: 135 1962
4 Raby C. Hemorragias y trombosis. In: Exploración del tiempo trombodinámico. Toray-Masson; Barcelona: 1968: 190-211
5 Lee BY, Trainor FS, Kavner D, McCann WJ. Monitoring of heparin therapy with thromboelastography. Surg Gynecol Obstet 149: 843-846 1979;
6 Caprini JA, Vagher JP, Rabidi SJ, Mitchell JE. Laboratory monitoring of continuous intravenous heparin therapy. Thromb Res 29: 91-94 1983;
7 Spiess BD, Tuman KJ, McCarthy RJ, Delaria GA, Schilo R, Ivancovich AD. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 3: 25-30 1987;
8 Tuman KJ, Spiess BD, Schoen RE, Ivankovich AD. Use of thromboelastography in the management of von Willebrand's disease during cardiopulmonary bypass. J Cardiothorac Anesth 1: 321-324 1987;
9 Gillies BSA, Spiess BD. Cardiopulmonary bypass coagulation management, education, and transfusion practice at the University of Washington. Am Society of Anesthesiology. October 1991 (Abst)
10 Soloway HB, Cox SP. In vitro comparison of the thrombin time and activated partial thromboplastin time in the laboratory control of heparin therapy. Am J Clin Pathol 60: 648-650 1973;
11 Bird R, Hall B, Hobbs KEF, Chapman D. : New haemocompatible polymers assessed by thromboelastography. J Biomed Eng 11: 231-234 1989;
12 Caprini JA, Eckenhoff JB, Ramstack JM, Zuckerman L, Mockros LF. Contact activation of heparinized plasma. Thromb Res 5: 379-400 1974;
13 Lee BY, Thoden WR, Del Guercio LRM et al Monitoring coagulation dynamics with thromboelastography. Contemp Surg 24: 19-24 1984;
14 Coppola L, Giunta R, Spiezia R, Nappo V, Scognamiglio C, Tirelli A. Accentuata ed irregolare detlessione postmassimale nei tracciati tromboelastografici: Incidenza in varie patologie. Boll Soc It Biol Sper 61: 263-270 1985;
15 Jespersen J. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Danish Med Bull 35: 1-33 1988;
16 De Gaetano G, Vermylen J. Effect of aspirin on the thrombelastogram of human blood. Thromb Diath Haemorrh 30: 494-498 1973;
17 Tuman KJ, McCarthy RJ, Patel RV, Patel RB, Ivankovich AD. Comparison of thromboelastography and platelet aggregometry. (Abst.) Anesthesiology 75: A433 1991;
18 Laster J. The heparin induced thrombocytopenic syndrome: An update. Surgery 102: 763-770 1987;
19 Copeland JG, Harker LA, Joist JH, De Vries WC. Circulatory support 1988. Bleeding and anticoagulation. Ann Thorac Surg 47: 87-95 1989;
20 Zuckerman L, Ramstack JM, Vagher JP, Caprini JA, Mockros LF. Neutralization of heparin by cellular blood elements. Thromb Res 7: 149-159 1975;
21 Ramstack JM, Zuckerman L, Mockros LF, Caprini JA, Vagher JP. Effect on platelet count and hematocrit on the coagulability of heparinized blood. Res Commun Chem Pathol Pharmacol 21: 327-341 1978;
22 Howland WS, Castro B, Fortner J, Gould P. Hypercoagulability, thrombelastographic monitoring during extensive hepatic surgery. Arch Surg 108: 605-608 1974;
23 Vagher JP, Caprini JA, Zuckerman L. Multi-system analysis of intravenous calcium and sodium heparin. Thromb Res 14: 881-900 1979;
24 De Takats G. Heparin tolerance. A test of the clotting mechanism. Surg Gynecol Obstet 77: 31-39 1943;
25 Traverso CI. Valoración del test de tolerancia a la heparina intravenosa realizado con tromboelastografia en la predicción de la enfermedad tromboembó1ica venosa tras cirugía general electiva. Granada University School of Medicine. Spain: doctoral thesis 1989
26 Lee BY, Trainor FS, Thoden WR, Kavner D. Handbook of Noninvasive Diagnostic Techniques in Vascular Surgery. Monitoring coagulation dynamics: Thromboelastography. In: Appleton-Century-Crofts; New York: 1981: 266-286
27 Bull HS, Huse WN, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 69: 685-689 1975;
28 Friesen RH, Clement AJ. Individual responses to heparinization for extracorporeal circulation. J Thorac Cardiovasc Surg 72: 875-879 1976;
29 Whitfield L, Schentag J, Levy G. Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: magnitude and predictability of interindividual differences. Clin Pharmacol Ther 32: 503-516 1982;
30 Mockros LF, Hirsch SD, Zuckerman L, Caprini JA, Robinson WP, Vagher JP. Anticoagulation kinetics following bolus injection of heparin. Thromb Haemostas 42: 1248-1260 1979;
31 Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 95: 37s-51s 1989;
32 Walker A, Jick H. Predictors of bleeding during heparin therapy. JAMA 244: 1209-1212 1980;
33 Lee B, Taha S, Trainor F, Kavner D, McCann M. Monitoring heparin therapy with thromboelastography and activated partial thromboplastin time. World J Surg 4: 232-239 1980;
34 Raby C. Coagulaciones intravasculares diseminadas y localizadas. Toray-Masson; Barcelona: 1976: 255
35 Traverso CI. Estudio de las modificaciones tromboelastognificas inducidas por la heparina a bajas dosis y el dextrano 70 como profilaxis de la enfermedad tromboembó1ica venosa postoperatoria. Granada University School of Medicine. Spain: medical degree thesis, 1986
36 Aznar J, Soto F, Villa P, Lonjedo L, Bulufer P. Valoración tromboelastográfica de la hipercoagulabilidad plasmática. Sangre 24: 1-8 1979;
37 Torras-Barba J, Duran J, Pales A, Alloza J, Monasterio J, Triginer A. Valoración tromboelastográfica de la hipercoagulabilidad en pacientes traumatológicos sometidos a profilaxis con heparina cálcica. Sangre 25: 35-44 1980;
38 Arcelus JI, Traverso CI, López-Cantarero M et al. Estudio de las modificaciones tromboelastográficas inducidas por la heparinizción profiláctica en cirugía general. Cir Esp 43: 518-526 1988;
39 Butler MJ. Thromboelastography during and after elective abdominal surgery. Thromb Haemostas 39: 488-495 1978;
40 Fano R, Gonzalez H. Valor de la tromboelastografia en la detección de la hipercoagulabilidad plasmatica. Barcelona Quir 26: 288-294 1983;
41 Sagar S, Massey J, Sanderson JM. Low-dose heparin prophylaxis against fatal pulmonary embolism. Br M ed J 4: 257-261 1975;
42 Raby C, Couinaud C. Les trubles de la coagulation dans les hemorragies des hypertensions portales. Chirugie 102: 186-196 1976;
43 Duraffourd P. Les conditions de la fiabilite et les avantages du thromboelastogramme. Coeur 12: 447-455 1981;
44 Vemese NA, Spillert CR, Franco CD, Lazaro EJ. Thromboelastographic evaluation of mini-dose heparin in minor surgical procedures. Am Surg 2: 112-113 1986;
45 Kakkar VV, Corrigan TA, Fossard DP. Prevention of fatal postoperative pulmonary embolism by low doses of heparin Reappraisal of results. Intemational multicenter trial. Lancet 1: 567-571 1977;
46 Leyvraz PF, Richard J, Bachmann F, VanMelle G, Treyvaud J-M, Livio J-J, Candardjis G. Adjusted versus fixed-dose heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 309: 954-958 1983;
47 Tabemer DA, Poller L, Thomson JM, Lemon G, Weighill FJ. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg 76: 933-935 1989;